Publication | Closed Access

Evaluation of Clinical Outcomes According to HER2 Detection by Fluorescence In Situ Hybridization in Women with Metastatic Breast Cancer Treated with Trastuzumab

Her2 DetectionBreast OncologyCancer DetectionMedicinePathologyBreast CancerClinical OutcomesCancer TreatmentOncologyRadiation OncologySitu HybridizationHealth Sciences